1. Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model of Cancer
   Jessica Kalra et al, 2015, J Histochem Cytochem. CrossRef
2. Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun
   Qing Tang et al, 2015, Cellular Signalling CrossRef
3. Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression
   Sayani Mukherjee et al, 2021, Funct Integr Genomics CrossRef
4. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives
   Agata Górska et al, 2022, Cell. Mol. Life Sci. CrossRef
5. Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway
   Feng Zhou et al, 2023, Biomedicine & Pharmacotherapy CrossRef